Venture Capital

Updated:

RedMedtech Ventures

RedMedtech Ventures is a venture capital based in Apeldoorn; the Altss profile covers its classification, headquarters, registration, AUM band, and key...

RedMedtech Ventures logo

RedMedtech Ventures

RedMedtech Ventures is a private equity firm based in Apeldoorn, Netherlands. It focuses on a Venture Capital investment approach.

General information

Firm type

Venture Capital

Location

Region

Europe

Country

Netherlands

City

Apeldoorn

Corporate office

Apeldoorn, Netherlands

Sector focus

Digital HealthMedical Devices

Frequently asked questions

Does RedMedtech Ventures invest outside the Netherlands?

Yes, the firm sources deals across Western Europe with a particular emphasis on the Benelux region, Germany, and the Nordic countries. These geographies produce a disproportionate share of medtech university spin-outs and have mature clinical trial infrastructure. RedMedtech evaluates opportunities in other European markets when the regulatory pathway and reimbursement landscape are well-defined.

How does RedMedtech Ventures differ from generalist Dutch venture firms?

RedMedtech operates as a dedicated medtech sector fund rather than a diversified venture or private equity platform. Generalist investors often lack in-house expertise to assess technical files, clinical investigation plans, and notified-body interactions that determine a device startup's viability. By restricting its mandate to regulated medical technology, the firm runs a diligence process built for CE-marking timelines and health technology appraisal rather than software go-to-market speed.

What types of medical technology does RedMedtech Ventures avoid?

The firm does not invest in wellness apps, unregulated health software, or consumer wearables that lack a medical purpose under EU MDR definitions. It also avoids therapeutics, biopharma, and drug discovery, maintaining a strict boundary between medtech and adjacent life sciences sectors where the regulatory and reimbursement frameworks differ substantially.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Apeldoorn Venture Capital profiles